Size isn't everything - ALLHAT in perspective

Journal of Hypertension

Volumn 21, Issue 3, 2003, Pages 459-461

  McInnes, Gordon T ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; LISINOPRIL;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE REGULATION; HUMAN; HYPERTENSION; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW;

EID: 0037359450     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200303000-00003     Document Type: Review

References (19)

1. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994; 50:272-298.
2. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
3. Kaplan NM: How bad are diuretic-induced hypokalaemia and hypercholesterolaemia? Arch Intern Med 1989, 149:2649.
4. Poole-Wilson PA: Hypokalaemia induced by thiazide diuretics in the treatment of hypertension: a cause for concern, not nihilism. Postgrad Med J 1983, 59 (Suppl 3): 137.
5. Poulter N, Sever P, Thom S. Antihypertensive and adverse biochemical effects of bendrofluazide. BMJ 1990; 300:1465.
6. Robertson JIS. Hypertension and coronary risk: possible adverse effects of antihypertensive drugs. Am Heart J 1987; 114:S1051-S1054.
7. Weinberger MH. Diuretics and their side-effects. Dilemma in the treatment of hypertension. Hypertension 1988; 11 (Suppl II):II-16-II-20.
8. Hansson L, Lindholm LH, Ekbom T, Dahlöf B, Lanke J, Schersten B, et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 Study. Lancet 1999; 354:1751-1756.
9. Hansson L, Lindholm LH, Niskanen L Lanke J, Hedner T, Niklason A, et al. Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999; 353:611-616.
10. Brown MJ, Palmer CR, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, Ruilope LM. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium channel blocker or diuretic in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356:366-377.
11. Hansson L, Helmer T, Lund-Johannsen P, Kjeldsen SE, Lindholm L, Syvertsen JO, et al. Randomised trial of efforts of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) Study. Lancet 2000; 356:359-365.
12. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000; 355:1955-1964.
13. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 2002; 288:2981-2997.
14. Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358:1305-1315.
15. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351:1755-1762
16. Tuomilehto J, Rastenyte D, Birkenhager WH, Thijs L, Antikainen R, Bulpitt CJ, et al. Effects of calcium channel blockers in older patients with diabetes and systolic hypertension. N Engl J Med 1999; 340:677-684.
17. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major cardiovascular events on hypertensive patients randomized to doxazosin vs chlorthalidone. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2000; 283:1967-1975.
18. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-2461.
19. McInnes GT, Yeo WW, Ramsay LE, Moser M. Cardiotoxicity and diuretics: much speculation · little substance. J Hypertens 1992; 10:317-335.